Myocardial Infarction Risk for Women with Breast Cancer: Annotated Bibliography
Abdel-Qadir, H., Amir, E., Fischer, H. D., Fu, L., Austin, P. C., Harvey, P. J., ... & Anderson, G. M. (2016). The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer. European Journal of Cancer, 68, 11-21.
The rationale for this study was that a gap in the literature existed with respect to the possibility of aromatase inhibitors increasing cardiovascular risk relative to tamoxifen among breast cancer patients who were in the post-menopause phase of life. The participants consisted of more 9500 women over the age of 55 suffering from breast cancer (stage 1 to 3) in Ontario, Canada. The researchers conducted an observational cohort study to observe the myocardial infarction risk of aromatase inhibitors and tamoxifen. They examined cases of hospitalization of the population sampled as a result of myocardial infarction and compared cases of those being treated with aromatase inhibitors to those being treated with tamoxifen.
The researchers found that aromatase inhibitors were associated with higher risk of myocardial infarction compared to risk associated with tamoxifen. The implications for clinical practice are that nurses and physicians should consider restricting treatment of breast cancer in post-menopausal women to tamoxifen and not use aromatase inhibitors such as Arimidex, Aromasin or Femara as these can raise the risk of myocardial infarction. Reduction of aromatase inhibitors could help to lower the rate of hospitalization for myocardial infarction for this particular population as well.
Cheng, Y. J., Nie, X. Y., Ji, C. C., Lin, X. X., Liu, L. J., Chen, X. M., ... & Wu, S. H. (2017). Long?Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer. Journal of the American Heart Association, 6(5), e005633.
The rationale for this study was to obtain quantitative data that...
Jones, L. W., Habel, L. A., Weltzien, E., Castillo, A., Gupta, D., Kroenke, C. H., ... & Yu, A. (2016). Exercise and risk of cardiovascular events in women with nonmetastatic breast cancer. Journal of Clinical Oncology, 34(23), 2743.
James, M., Swadi, S., Yi, M., Johansson, L., Robinson, B., & Dixit, A. (2018). Ischaemic heart disease following conventional and hypofractionated radiation treatment in a contemporary breast cancer series. Journal of medical imaging and radiation oncology.
Abdel-Qadir, H., Amir, E., Fischer, H. D., Fu, L., Austin, P. C., Harvey, P. J., ... & Anderson, G. M. (2016). The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer. European Journal of Cancer, 68, 11-21.
Cheng, Y. J., Nie, X. Y., Ji, C. C., Lin, X. X., Liu, L. J., Chen, X. M., ... & Wu, S. H. (2017). Long?Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer. Journal of the American Heart Association, 6(5), e005633.
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D.,... & Jensen, M. B. (2013). Risk of ischemic heart disease in women after radiotherapy for breast cancer. New England Journal of Medicine, 368(11), 987-998.
Myocardial Infarction According to the Centers for Disease Control and Prevention (CDC, 2006), each year approximately 1.2 million Americans suffer from myocardial infarction (heart attack) each year. 40% of these people who a have heart attack will die from it. This equates to a person having a heart attack every 34 seconds, and a person dying from a heart attack every minute. Heart disease is the leading cause of death in
MI Case Study: Myocardial Infarction At 10:05 A.M., the blockage that had been silently growing in Paul Parker's left coronary artery made its sinister presence known. The 54-year-old accounting executive had arrived with his family at the Denver zoo feeling fine, but suddenly a dull ache started in the center of his chest and he became nauseated. At first he brushed it off as the aftereffects of a company dinner the night
Acute Myocardial Infarction PATHOPHYSIOLOGICAL PROCESS TEMPLATE DISEASE: Acute Myocardial Infarction is a common disease with very grave consequences in morbidity, mortality and cost to the society (Boersma et.al, 2003) It has become the leading cause of death in the developed world. It has been estimated that about 450,000 people die from coronary disease per year in the United States. Myocardial infarction primarily occurs when the blood supply to the heart is compromised. Just like
Health Care Services for Myocardial Infarction: Myocardial Infarction (MI) is commonly known as Acute Myocardial Infarction (AMI) is a heart attack disease in which blood supply to a part of the heart is interrupted resulting in ultimate irreversible damage and cell death in that part of the heart (Khan, 2010). As one of cardiovascular diseases, myocardial infarction can be regarded as one of the leading causes of death for men
5% while 70.5% took Aspirin within six hours after reaching hospital and 76.5% of patients admitted in the NICVD were receiving Aspirin therapy." (Jaiwa, 2006, p.1) Jaiwa reports a more recent study that states findings that out of 52 patients with chest pain only 13 patients or 25% of the 52 received aspirin. The stated reason for not giving aspirin to the other 39 patients included that "chest pain was not
This thickening, hardening, calcification and the fatty deposits all work together to block the arteries causing the deprivation of blood. Cigarette smoking is another contributor to the damaging process. It can cause an increased heart rate and hypertension, both of which causes the heart to work harder than what it should. "Cigarette smoke contains carbon dioxide" (MedicineNet.com, 2007) and when inhaled into the body can lead to less oxygen in
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now